[Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment]. [electronic resource]
- Zhonghua yi xue za zhi Sep 2009
- 2404-7 p. digital
2-Pyridinylmethylsulfinylbenzimidazoles--therapeutic use Adult Aged Anti-Ulcer Agents--therapeutic use Female Follow-Up Studies Gastroesophageal Reflux--drug therapy Humans Longitudinal Studies Male Middle Aged Quality of Life Rabeprazole Treatment Outcome